"Myasthenia Gravis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A disorder of neuromuscular transmission characterized by weakness of cranial and skeletal muscles. Autoantibodies directed against acetylcholine receptors damage the motor endplate portion of the NEUROMUSCULAR JUNCTION, impairing the transmission of impulses to skeletal muscles. Clinical manifestations may include diplopia, ptosis, and weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles. THYMOMA is commonly associated with this condition. (Adams et al., Principles of Neurology, 6th ed, p1459)
| Descriptor ID |
D009157
|
| MeSH Number(s) |
C10.114.656 C10.668.758.725 C20.111.258.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Myasthenia Gravis".
Below are MeSH descriptors whose meaning is more specific than "Myasthenia Gravis".
This graph shows the total number of publications written about "Myasthenia Gravis" by people in this website by year, and whether "Myasthenia Gravis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Myasthenia Gravis" by people in Profiles.
-
Dalakas MC. Advances in the therapeutic algorithm for myasthenia gravis. Nat Rev Neurol. 2023 Jul; 19(7):393-394.
-
Dalakas MC, Meisel A. Immunomodulatory effects and clinical benefits of intravenous immunoglobulin in myasthenia gravis. Expert Rev Neurother. 2022 Apr; 22(4):313-318.
-
Balabbigari N, Purewal J, Sakul N, Purewal A, Kankanala V, Califano T. Cranial Nerve IX and X Weakness: An Unusual Initial Presentation of Myasthenia Gravis. Am J Case Rep. 2020 Aug 10; 21:e923750.
-
Aktas A, Rojas E, Parikh HA, Pergament K. Myasthenia gravis crisis coinciding with asthma exacerbation in a patient with recent heroin use: three causes of acute hypercarbic respiratory failure. BMJ Case Rep. 2018 Oct 07; 2018.
-
Alnahhas I, Wong J. A case of new-onset antibody-positive myasthenia gravis in a patient treated with pembrolizumab for melanoma. Muscle Nerve. 2017 06; 55(6):E25-E26.
-
White M, Meenan K, Patel T, Jaworek A, Sataloff RT. Laboratory Evaluation of Vocal Fold Paralysis and Paresis. J Voice. 2017 Mar; 31(2):168-174.
-
Weksler B, Tavares J, Newhook TE, Greenleaf CE, Diehl JT. Robot-assisted thymectomy is superior to transsternal thymectomy. Surg Endosc. 2012 Jan; 26(1):261-6.
-
Callaghan B, Moster ML, Bird SJ. Myasthenia gravis with presynaptic electrophysiologic abnormalities. J Clin Neuromuscul Dis. 2009 Jun; 10(4):185-90.
-
Dalakas M. IVIg in other autoimmune neurological disorders: current status and future prospects. J Neurol. 2008 Jul; 255 Suppl 3:12-6.
-
Levitan R. Safety of succinylcholine in myasthenia gravis. Ann Emerg Med. 2005 Feb; 45(2):225-6.